User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Whole Body MRI and oncology: recent major advances

Primary tabs

Pasoglou, Vasiliki [UCL] Michoux, Nicolas [UCL] Larbi, Ahmed [UCL] Van Nieuwenhove, Sandy [UCL] Lecouvet, Frédéric [UCL]

Magnetic Resonance Imaging (MRI) is a very attractive approach for tumor detection and oncological staging with its absence of ionizing radiation, high soft tissue contrast and spatial resolution. Less than ten years ago the use of Whole Body MRI (WB-MRI) protocols was uncommon due to many limitations, such as the long acquisition times and limited availability. This decade has marked substantial progress in WB-MRI protocols. This very promising technique is rapidly arising from the research world and is becoming a commonly used exam for tumor detection, due to recent technological developments and validation of WB-MRI by multiple studies and consensus papers. As a result, WB-MRI is progressively proposed by radiologists as an efficient exam for an expanding range of indications. As the spectrum of its uses becomes wider, radiologists will soon be confronted with the challenges of this technique and be urged to be trained in order to accurately read and report these exams. The aim of this review is to summarize the validated indications of WB-MRI and present an overview of its most recent advances. This paper will briefly discuss how this exam is performed and which are the recommended sequences along with the future perspectives in the field.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 2018
Language Anglais
Journal information "British Journal of Radiology" - Vol. 91, no. 1090, p. 20170664 (2018)
Peer reviewed yes
Publisher British Institute of Radiology ((United Kingdom) London)
issn 0007-1285
e-issn 1748-880X
Publication status Publié
Affiliations UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale
UCL - (SLuc) Service de radiologie
UCL - SSS/IONS/NEUR - Clinical Neuroscience
Links
  1. Takahara T., Radiat Med, 22, 275 (2004)
  2. Padhani Anwar R., Liu Guoying, Mu-Koh Dow, Chenevert Thomas L., Thoeny Harriet C., Takahara Taro, Dzik-Jurasz Andrew, Ross Brian D., Van Cauteren Marc, Collins David, Hammoud Dima A., Rustin Gordon J.S., Taouli Bachir, Choyke Peter L., Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations, 10.1593/neo.81328
  3. Lecouvet Frédéric E., Whole-Body MR Imaging: Musculoskeletal Applications, 10.1148/radiol.2016142084
  4. Wu Lian-Ming, Gu Hai-Yan, Zheng Jasmine, Xu Xiao, Lin Lin-Hua, Deng Xia, Zhang Wei, Xu Jian-Rong, Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis, 10.1002/jmri.22608
  5. Fischer Michael A., Nanz Daniel, Hany Thomas, Reiner Caecilia S., Stolzmann Paul, Donati Olivio F., Breitenstein Stefan, Schneider Paul, Weishaupt Dominik, von Schulthess Gustav K., Scheffel Hans, Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT, 10.1007/s00330-010-1929-x
  6. Pasoglou Vasiliki, Larbi Ahmed, Collette Laurence, Annet Laurence, Jamar François, Machiels Jean-Pascal, Michoux Nicolas, Berg Bruno C. Vande, Tombal Bertrand, Lecouvet Frederic E., One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all-in-one” imaging approach? : One Step TNM Staging of Prostate Cancer Using MRI, 10.1002/pros.22764
  7. Tombal Bertrand, Lecouvet Frederic, Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?, 10.1155/2012/893193
  8. Engelhard K., Hollenbach H. P., Wohlfart K., von Imhoff E., Fellner F. A., Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer, 10.1007/s00330-003-1968-7
  9. Gutzeit Andreas, Doert Aleksis, Froehlich Johannes M., Eckhardt Boris P., Meili Andreas, Scherr Patrick, Schmid Daniel T., Graf Nicole, von Weymarn Constantin A., Willemse Edwin M. M., Binkert Christoph A., Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma, 10.1007/s00256-009-0789-4
  10. Schmidt Gerwin P., Baur-Melnyk Andrea, Herzog Peter, Schmid Rupert, Tiling Reinhold, Schmidt Michael, Reiser Maximilian F., Schoenberg Stefan O., High-Resolution Whole-Body Magnetic Resonance Image Tumor Staging With the Use of Parallel Imaging Versus Dual-Modality Positron Emission Tomography???Computed Tomography : Experience on a 32-Channel System, 10.1097/01.rli.0000185878.61270.b0
  11. Schmidt Gerwin P., Baur-Melnyk Andrea, Haug Alexander, Heinemann Volker, Bauerfeind Ingo, Reiser Maximilian F., Schoenberg Stefan O., Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3T compared to FDG–PET–CT, 10.1016/j.ejrad.2007.10.021
  12. Ohno Yoshiharu, Koyama Hisanobu, Nogami Munenobu, Takenaka Daisuke, Yoshikawa Takeshi, Yoshimura Masahiro, Kotani Yoshikazu, Nishimura Yoshihiro, Higashino Takanori, Sugimura Kazuro, Whole-body MR imaging vs. FDG-PET: Comparison of accuracy of M-stage diagnosis for lung cancer patients, 10.1002/jmri.21031
  13. Ohno Y., Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non-small cell Iung cancer. J Magn Reson Imaging (2017)
  14. Shen Guohua, Deng Houfu, Hu Shuang, Jia Zhiyun, Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis, 10.1007/s00256-014-1903-9
  15. Conde-Moreno A. J., Herrando-Parreño G., Muelas-Soria R., Ferrer-Rebolleda J., Broseta-Torres R., Cozar-Santiago M. P., García-Piñón F., Ferrer-Albiach C., Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer, 10.1007/s12094-016-1563-4
  16. Ghosh Arundhati, Heston Warren D.W., Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer, 10.1002/jcb.10661
  17. Afshar-Oromieh Ali, Zechmann Christian M., Malcher Anna, Eder Matthias, Eisenhut Michael, Linhart Heinz G., Holland-Letz Tim, Hadaschik Boris A., Giesel Frederik L., Debus Jürgen, Haberkorn Uwe, Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer, 10.1007/s00259-013-2525-5
  18. Afshar-Oromieh Ali, Haberkorn Uwe, Hadaschik Boris, Habl Gregor, Eder Matthias, Eisenhut Michael, Schlemmer Heinz-Peter, Roethke Matthias C., PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer, 10.1007/s00259-013-2489-5
  19. Gupta Manoj, Choudhury ParthaS, Hazarika Dibyamohan, Rawal Sudhir, A comparative study of 68Gallium-prostate specific membrane antigen positron emission tomography-computed tomography and magnetic resonance imaging for lymph node staging in high risk prostate cancer patients: An initial experience, 10.4103/1450-1147.207272
  20. Afshar-Oromieh Ali, Avtzi Eleni, Giesel Frederik L., Holland-Letz Tim, Linhart Heinz G., Eder Matthias, Eisenhut Michael, Boxler Silvan, Hadaschik Boris A., Kratochwil Clemens, Weichert Wilko, Kopka Klaus, Debus Jürgen, Haberkorn Uwe, The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer, 10.1007/s00259-014-2949-6
  21. Obek C., Eur J Nucl Med Mol Imaging (2017)
  22. Mottet Nicolas, Bellmunt Joaquim, Bolla Michel, Briers Erik, Cumberbatch Marcus G., De Santis Maria, Fossati Nicola, Gross Tobias, Henry Ann M., Joniau Steven, Lam Thomas B., Mason Malcolm D., Matveev Vsevolod B., Moldovan Paul C., van den Bergh Roderick C.N., Van den Broeck Thomas, van der Poel Henk G., van der Kwast Theo H., Rouvière Olivier, Schoots Ivo G., Wiegel Thomas, Cornford Philip, EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent, 10.1016/j.eururo.2016.08.003
  23. Albers P., Albrecht W., Algaba F., Bokemeyer C., Cohn-Cedermark G., Fizazi K., Horwich A., Laguna M.P., Guía clínica sobre el cáncer de testículo de la EAU: actualización de 2011, 10.1016/j.acuro.2011.06.017
  24. van As N J, Gilbert D C, Money-Kyrle J, Bloomfield D, Beesley S, Dearnaley D P, Horwich A, Huddart R A, Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse, 10.1038/sj.bjc.6604280
  25. Mosavi Firas, Laurell Anna, Ahlström Håkan, Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer, 10.3109/0284186x.2015.1043027
  26. Sohaib S.A., Koh D.M., Barbachano Y., Parikh J., Husband J.E.S., Dearnaley D.P., Horwich A., Huddart R., Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours, 10.1016/j.crad.2008.10.011
  27. Ruf Juri, Heuck Friederike, Schiefer Jan, Denecke Timm, Elgeti Florian, Pascher Andreas, Pavel Marianne, Stelter Lars, Kropf Siegfried, Wiedenmann Bertram, Amthauer Holger, Impact of Multiphase68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors, 10.1159/000265561
  28. Buchmann I., Henze M., Engelbrecht S., Eisenhut M., Runz A., Schäfer M., Schilling T., Haufe S., Herrmann T., Haberkorn U., Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours, 10.1007/s00259-007-0450-1
  29. Kwekkeboom D. J, Kam B. L, van Essen M., Teunissen J. J M, van Eijck C. H J, Valkema R., de Jong M., de Herder W. W, Krenning E. P, Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors, 10.1677/erc-09-0078
  30. Carlbom Lina, Caballero-Corbalán José, Granberg Dan, Sörensen Jens, Eriksson Barbro, Ahlström Håkan, Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors, 10.1080/03009734.2016.1248803
  31. Etchebehere E. C. S. d. C., de Oliveira Santos A., Gumz B., Vicente A., Hoff P. G., Corradi G., Ichiki W. A., de Almeida Filho J. G., Cantoni S., Camargo E. E., Costa F. P., 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-Octreotide SPECT/CT, and Whole-Body MR Imaging in Detection of Neuroendocrine Tumors: A Prospective Trial, 10.2967/jnumed.114.144543
  32. Moryoussef Frederick, de Mestier Louis, Belkebir Mohamed, Deguelte-Lardière Sophie, Brixi Hedia, Kianmanesh Reza, Hoeffel Christine, Cadiot Guillaume, Impact of Liver and Whole-Body Diffusion-Weighted MRI for Neuroendocrine Tumors on Patient Management: A Pilot Study, 10.1159/000446369
  33. Müller-Horvat Christian, Radny Peter, Eigentler Thomas K., Schäfer Jürgen, Pfannenberg Christina, Horger Marius, Khorchidi Sascha, Nägele Thomas, Garbe Claus, Claussen Claus D., Schlemmer Heinz-Peter, Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma, 10.1016/j.ejca.2005.10.008
  34. Pfannenberg Christina, Aschoff Philip, Schanz Sandra, Eschmann Susanne M., Plathow Christian, Eigentler Thomas K., Garbe Claus, Brechtel Klaus, Vonthein Reinhard, Bares Roland, Claussen Claus D., Schlemmer Heinz P., Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma, 10.1016/j.ejca.2006.11.014
  35. Pflugfelder A., J Dtsch Dermatol Ges, 11, 1 (2013)
  36. Dummer R., Swiss Med Wkly, 146, w14279 (2016)
  37. Zamagni E., Nanni C., Patriarca F., Englaro E., Castellucci P., Geatti O., Tosi P., Tacchetti P., Cangini D., Perrone G., Ceccolini M., Brioli A., Buttignol S., Fanin R., Salizzoni E., Baccarani M., Fanti S., Cavo M., A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma, 10.3324/haematol.10554
  38. Gleeson T. G., Moriarty J., Shortt C. P., Gleeson J. P., Fitzpatrick P., Byrne B., McHugh J., O’Connell M., O’Gorman P., Eustace S. J., Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI), 10.1007/s00256-008-0607-4
  39. Dimopoulos Meletios A., Hillengass Jens, Usmani Saad, Zamagni Elena, Lentzsch Suzanne, Davies Faith E., Raje Noopur, Sezer Orhan, Zweegman Sonja, Shah Jatin, Badros Ashraf, Shimizu Kazuyuki, Moreau Philippe, Chim Chor-Sang, Lahuerta Juan José, Hou Jian, Jurczyszyn Artur, Goldschmidt Hartmut, Sonneveld Pieter, Palumbo Antonio, Ludwig Heinz, Cavo Michele, Barlogie Bart, Anderson Kenneth, Roodman G. David, Rajkumar S. Vincent, Durie Brian G.M., Terpos Evangelos, Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement, 10.1200/jco.2014.57.9961
  40. Excellence N.N.I.f.H.a.C., Myeloma: diagnosis and management (2016)
  41. Chantry Andrew, Kazmi Majid, Barrington Sally, Goh Vicky, Mulholland Nicola, Streetly Matthew, Lai Maggie, Pratt Guy, , Guidelines for the use of imaging in the management of patients with myeloma, 10.1111/bjh.14827
  42. Bäuerle Tobias, Hillengass Jens, Fechtner Kerstin, Zechmann Christian M., Grenacher Lars, Moehler Thomas M., Christiane Heiss, Barbara Wagner-Gund, Neben Kai, Kauczor Hans-Ulrich, Goldschmidt Hartmut, Delorme Stefan, Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging, 10.1148/radiol.2522081756
  43. Rasche Leo, Angtuaco Edgardo, McDonald James E., Buros Amy, Stein Caleb, Pawlyn Charlotte, Thanendrarajan Sharmilan, Schinke Carolina, Samant Rohan, Yaccoby Shmuel, Walker Brian A., Epstein Joshua, Zangari Maurizio, van Rhee Frits, Meissner Tobias, Goldschmidt Hartmut, Hemminki Kari, Houlston Richard, Barlogie Bart, Davies Faith E., Morgan Gareth J., Weinhold Niels, Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma, 10.1182/blood-2017-03-774422
  44. Dixon W T, Simple proton spectroscopic imaging., 10.1148/radiology.153.1.6089263
  45. Bray Timothy J. P., Singh Saurabh, Latifoltojar Arash, Rajesparan Kannan, Rahman Farzana, Narayanan Priya, Naaseri Sahar, Lopes Andre, Bainbridge Alan, Punwani Shonit, Hall-Craggs Margaret A., Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study, 10.1371/journal.pone.0180562
  46. Carbone P.P., Cancer Res, 31, 1860 (1971)
  47. Lister T A, Crowther D, Sutcliffe S B, Glatstein E, Canellos G P, Young R C, Rosenberg S A, Coltman C A, Tubiana M, Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting., 10.1200/jco.1989.7.11.1630
  48. Wang Jun, Weiss Lawrence M., Chang Karen L., Slovak Marilyn L., Gaal Karl, Forman Stephen J., Arber Daniel A., Diagnostic utility of bilateral bone marrow examination : Significance of morphologic and ancillary technique study in malignancy, 10.1002/cncr.10364
  49. Coller B.S., Am J Hematol (1977)
  50. Connors Joseph M., State-of-the-Art Therapeutics: Hodgkin's Lymphoma, 10.1200/jco.2005.05.016
  51. Punwani Shonit, Taylor Stuart A., Saad Ziauddin Z., Bainbridge Alan, Groves Ashley, Daw Stephen, Shankar Ananth, Halligan Steve, Humphries Paul D., Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?, 10.1007/s00259-012-2293-7
  52. Adams Hugo J.A., Kwee Thomas C., Lokhorst Henk M., Westerweel Peter E., Fijnheer Rob, Kersten Marie José, Verkooijen Helena M., Stoker Jaap, Nievelstein Rutger A.J., Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy : Whole-Body Bone Marrow MRI in DLBCL, 10.1002/jmri.24318
  53. Albano Domenico, Patti Caterina, Lagalla Roberto, Midiri Massimo, Galia Massimo, Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma : Whole-Body MRI in Lymphoma Marrow Involvement, 10.1002/jmri.25439
  54. Tsunoda S., Blood, 89, 286 (1997)
  55. Jerusalem G., Beguin Y., Najjar F., Hustinx R., Fassotte M. F., Rigo P., Fillet G., Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)*, 10.1023/a:1011169332265
  56. Karam Maroun, Novak Leon, Cyriac Jomol, Ali Ameera, Nazeer Tipu, Nugent Francis, Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas, 10.1002/cncr.21967
  57. Elstrom R., Utility of FDG-PET scanning in lymphoma by WHO classification, 10.1182/blood-2002-09-2778
  58. Ray J.G., Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA (2016)
  59. Villani Anita, Tabori Uri, Schiffman Joshua, Shlien Adam, Beyene Joseph, Druker Harriet, Novokmet Ana, Finlay Jonathan, Malkin David, Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study, 10.1016/s1470-2045(11)70119-x
  60. Monsalve Johanna, Kapur Jeevesh, Malkin David, Babyn Paul S., Imaging of Cancer Predisposition Syndromes in Children, 10.1148/rg.311105099
  61. Friedman Danielle Novetsky, Lis Eric, Sklar Charles A., Oeffinger Kevin C., Reppucci Marina, Fleischut Megan Harlan, Francis Jasmine H., Marr Brian, Abramson David H, Dunkel Ira J, Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: A pilot study : Whole-body magnetic resonance imaging (WB-MRI), 10.1002/pbc.24835
  62. Anupindi Sudha A., Bedoya Maria A., Lindell Robert B., Rambhatla Siri J., Zelley Kristin, Nichols Kim E., Chauvin Nancy A., Diagnostic Performance of Whole-Body MRI as a Tool for Cancer Screening in Children With Genetic Cancer-Predisposing Conditions, 10.2214/ajr.14.13663
  63. Ballinger M.L., JAMA Oncol (2017)
  64. Goo Hyun Woo, Yang Dong Hyun, Ra Young Shin, Song Joon Sup, Im Ho Joon, Seo Jong Jin, Ghim Thad, Moon Hyung Nam, Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy, 10.1007/s00247-006-0246-7
  65. Jasperson Kory W., Kohlmann Wendy, Gammon Amanda, Slack Heidi, Buchmann Luke, Hunt Jason, Kirchhoff Anne C., Baskin Henry, Shaaban Akram, Schiffman Joshua D., Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families, 10.1007/s10689-013-9639-6
  66. Koh Dow-Mu, Blackledge Matthew, Padhani Anwar R., Takahara Taro, Kwee Thomas C., Leach Martin O., Collins David J., Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls, 10.2214/ajr.11.7866
  67. Pasoglou Vasiliki, Michoux Nicolas, Tombal Bertrand, Jamar François, Lecouvet Frédéric E., wbMRI to detect bone metastases: critical review on diagnostic accuracy and comparison to other imaging modalities, 10.1007/s40336-015-0120-4
  68. Balliu E., Boada M., Peláez I., Vilanova J.C., Barceló-Vidal C., Rubio A., Galofré P., Castro A., Pedraza S., Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases, 10.1016/j.crad.2010.07.002
  69. NAKANISHI Katsuyuki, KOBAYASHI Midori, NAKAGUCHI Kazunori, KYAKUNO Miyaji, HASHIMOTO Nobuyuki, ONISHI Hiromitsu, MAEDA Noboru, NAKATA Saki, KUWABARA Masatomo, MURAKAMI Takamichi, NAKAMURA Hironobu, Whole-body MRI for Detecting Metastatic Bone Tumor: Diagnostic Value of Diffusion-weighted Images, 10.2463/mrms.6.147
  70. Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka J T, Melhem E R, Yucel E K, A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases., 10.2214/ajr.169.6.9393186
  71. Mosavi Firas, Johansson Silvia, Sandberg Dan T., Turesson Ingela, Sörensen Jens, Ahlström Håkan, Whole-Body Diffusion-Weighted MRI Compared With 18F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma, 10.2214/ajr.11.8351
  72. Lecouvet Frederic E., Lhommel Renaud, Pasoglou Vasiliki, Larbi Ahmed, Jamar François, Tombal Bertrand, Novel imaging techniques reshape the landscape in high-risk prostate cancers : , 10.1097/mou.0b013e328361d451
  73. Schmidt G.P., Paprottka P., Jakobs T.F., Hoffmann R.T., Baur-Melnyk A., Haug A., Notohamiprodjo M., Baur-Melnyk A., Nikolaou K., Reiser M.F., Rist C., FDG–PET–CT and whole-body MRI for triage in patients planned for radioembolisation therapy, 10.1016/j.ejrad.2011.02.018
  74. Ghanem N., Vivo, 20, 173 (2006)
  75. Walker R., Kessar P., Blanchard R., Dimasi M., Harper K., DeCarvalho V., Yucel E.K., Patriquin L., Eustace S., Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience, 10.1002/(sici)1522-2586(200004)11:4<343::aid-jmri1>3.0.co;2-p
  76. Latifoltojar Arash, Hall-Craggs Margaret, Bainbridge Alan, Rabin Neil, Popat Rakesh, Rismani Ali, D’Sa Shirley, Dikaios Nikolaos, Sokolska Magdalena, Antonelli Michela, Ourselin Sebastien, Yong Kwee, Taylor Stuart A., Halligan Steve, Punwani Shonit, Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction, 10.1007/s00330-017-4907-8
  77. Del Grande Filippo, Santini Francesco, Herzka Daniel A., Aro Michael R., Dean Cooper W., Gold Garry E., Carrino John A., Fat-Suppression Techniques for 3-T MR Imaging of the Musculoskeletal System, 10.1148/rg.341135130
  78. Costelloe Colleen M., Madewell John E., Kundra Vikas, Harrell Robyn K., Bassett Roland L., Ma Jingfei, Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: Clinical utility per sequence, 10.1016/j.mri.2012.10.017
  79. Latifoltojar Arash, Hall-Craggs Margaret, Rabin Neil, Popat Rakesh, Bainbridge Alan, Dikaios Nikolaos, Sokolska Magdalena, Rismani Ali, D'Sa Shirley, Punwani Shonit, Yong Kwee, Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response, 10.1111/bjh.14401
  80. Messiou C, Giles S, Collins D J, West S, Davies F E, Morgan G J, Desouza N M, Assessing response of myeloma bone disease with diffusion-weighted MRI, 10.1259/bjr/52759767
  81. Takasu Miyuki, Kaichi Yoko, Tani Chihiro, Date Shuji, Akiyama Yuji, Kuroda Yoshiaki, Sakai Akira, Awai Kazuo, Iterative Decomposition of Water and Fat with Echo Asymmetry and Least-Squares Estimation (IDEAL) Magnetic Resonance Imaging as a Biomarker for Symptomatic Multiple Myeloma, 10.1371/journal.pone.0116842
  82. Berglund Johan, Johansson Lars, Ahlström Håkan, Kullberg Joel, Three-point dixon method enables whole-body water and fat imaging of obese subjects, 10.1002/mrm.22385
  83. Shortt Conor P., Gleeson Tadhg G., Breen Karen A., McHugh John, O'Connell Martin J., O'Gorman Peter J., Eustace Stephen J., Whole-Body MRI Versus PET in Assessment of Multiple Myeloma Disease Activity, 10.2214/ajr.08.1633
  84. Krohmer S., Sorge I., Krausse A., Kluge R., Bierbach U., Marwede D., Kahn T., Hirsch W., Whole-body MRI for primary evaluation of malignant disease in children, 10.1016/j.ejrad.2009.01.037
  85. Pasoglou Vasiliki, Michoux Nicolas, Peeters Frank, Larbi Ahmed, Tombal Bertrand, Selleslagh Tom, Omoumi Patrick, Vande Berg Bruno C., Lecouvet Frédéric E., Whole-Body 3D T1-weighted MR Imaging in Patients with Prostate Cancer: Feasibility and Evaluation in Screening for Metastatic Disease, 10.1148/radiol.14141242
  86. Padhani Anwar R., Lecouvet Frederic E., Tunariu Nina, Koh Dow-Mu, De Keyzer Frederik, Collins David J., Sala Evis, Schlemmer Heinz Peter, Petralia Giuseppe, Vargas H. Alberto, Fanti Stefano, Tombal H. Bertrand, de Bono Johann, METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer, 10.1016/j.eururo.2016.05.033
  87. Ohlmann-Knafo S., Tarnoki A., Tarnoki D., Pickuth D., MR Diagnosis of Bone Metastases at 1.5 T and 3 T: Can STIR Imaging Be Omitted?, 10.1055/s-0035-1553207
  88. Horger Marius, Weisel Katja, Horger Wilhelm, Mroue Ali, Fenchel Michael, Lichy Matthias, Whole-Body Diffusion-Weighted MRI With Apparent Diffusion Coefficient Mapping for Early Response Monitoring in Multiple Myeloma: Preliminary Results, 10.2214/ajr.10.5979
  89. Messiou C., deSouza N.M., Diffusion Weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring, 10.3233/cbm-2009-0116
  90. Bannas Peter, Hentschel Hannah B., Bley Thorsten A., Treszl András, Eulenburg Christine, Derlin Thorsten, Yamamura Jin, Adam Gerhard, Stübig Thomas, Kröger Nicolaus, Weber Christoph, Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation, 10.1007/s00330-012-2445-y
  91. Mayerhoefer Marius E., Karanikas Georgios, Kletter Kurt, Kiesewetter Barbara, Weber Michael, Rausch Ivo, Pones Matthias, Simonitsch-Klupp Ingrid, Müllauer Leonhard, Dolak Werner, Lukas Julius, Raderer Markus, Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy? : A Preliminary Study in 15 Patients, 10.1097/rlu.0000000000001395
  92. Blackledge Matthew D., Collins David J., Tunariu Nina, Orton Matthew R., Padhani Anwar R., Leach Martin O., Koh Dow-Mu, Assessment of Treatment Response by Total Tumor Volume and Global Apparent Diffusion Coefficient Using Diffusion-Weighted MRI in Patients with Metastatic Bone Disease: A Feasibility Study, 10.1371/journal.pone.0091779
  93. Perez-Lopez Raquel, Mateo Joaquin, Mossop Helen, Blackledge Matthew D., Collins David J., Rata Mihaela, Morgan Veronica A., Macdonald Alison, Sandhu Shahneen, Lorente David, Rescigno Pasquale, Zafeiriou Zafeiris, Bianchini Diletta, Porta Nuria, Hall Emma, Leach Martin O., de Bono Johann S., Koh Dow-Mu, Tunariu Nina, Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study, 10.1148/radiol.2016160646
  94. Messiou C., Collins D. J., Giles S., de Bono J. S., Bianchini D., de Souza N. M., Assessing response in bone metastases in prostate cancer with diffusion weighted MRI, 10.1007/s00330-011-2173-8
  95. Reischauer Carolin, Froehlich Johannes M., Koh Dow-Mu, Graf Nicole, Padevit Christian, John Hubert, Binkert Christoph A., Boesiger Peter, Gutzeit Andreas, Bone Metastases from Prostate Cancer: Assessing Treatment Response by Using Diffusion-weighted Imaging and Functional Diffusion Maps—Initial Observations, 10.1148/radiol.10092469
  96. Hellman S, Weichselbaum R R, Oligometastases., 10.1200/jco.1995.13.1.8
  97. METASTATIC BREAST CANCER: RECOMMENDATIONS PROPOSAL FROM THE EUROPEAN SCHOOL OF ONCOLOGY (ESO)- MBC TASK FORCE, 10.1016/j.breast.2006.11.002
  98. Gillessen S., Fanti S., Omlin A., Reply to the letter to the editor ‘Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015’ by Gillessen et al., 10.1093/annonc/mdv360
  99. Gillessen S., Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 (2017)
  100. Ost Piet, Bossi Alberto, Decaestecker Karel, De Meerleer Gert, Giannarini Gianluca, Karnes R. Jeffrey, Roach Mack, Briganti Alberto, Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature, 10.1016/j.eururo.2014.09.004
  101. Antoch Gerald, Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in Oncology, 10.1001/jama.290.24.3199
  102. Heusner Till, Gölitz Philipp, Hamami Monia, Eberhardt Wilfried, Esser Stefan, Forsting Michael, Bockisch Andreas, Antoch Gerald, “One-stop-shop” staging: Should we prefer FDG-PET/CT or MRI for the detection of bone metastases?, 10.1016/j.ejrad.2009.10.031
  103. Robertson N.L., Combined whole-body and multi-parametric prostate MRI as a single-step approach for the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy. J Urol (2017)
  104. Griswold Mark A., Jakob Peter M., Heidemann Robin M., Nittka Mathias, Jellus Vladimir, Wang Jianmin, Kiefer Berthold, Haase Axel, Generalized autocalibrating partially parallel acquisitions (GRAPPA), 10.1002/mrm.10171
  105. Roemer P. B., Edelstein W. A., Hayes C. E., Souza S. P., Mueller O. M., The NMR phased array, 10.1002/mrm.1910160203
  106. Feinberg D A, Hale J D, Watts J C, Kaufman L, Mark A, Halving MR imaging time by conjugation: demonstration at 3.5 kG., 10.1148/radiology.161.2.3763926
  107. Kuhl C.K., Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen. Radiology (2017)
  108. Fascelli Michele, Rais-Bahrami Soroush, Sankineni Sandeep, Brown Anna M., George Arvin K., Ho Richard, Frye Thomas, Kilchevsky Amichai, Chelluri Raju, Abboud Steven, Siddiqui M. Minhaj, Merino Maria J., Wood Bradford J., Choyke Peter L., Pinto Peter A., Turkbey Baris, Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population, 10.1016/j.urology.2015.09.035
  109. Dzyubachyk Oleh, Staring Marius, Reijnierse Monique, Lelieveldt Boudewijn P. F., van der Geest Rob J., Inter-station intensity standardization for whole-body MR data : Inter-Station Intensity Standardization for Whole-Body MR Data, 10.1002/mrm.26098
  110. Dzyubachyk Oleh, Blaas Jorik, Botha Charl P., Staring Marius, Reijnierse Monique, Bloem Johan L., van der Geest Rob J., Lelieveldt Boudewijn P. F., Comparative exploration of whole-body MR through locally rigid transforms, 10.1007/s11548-013-0820-z
  111. Ceranka Jakub, Polfliet Mathias, Lecouvet Frédéric, Michoux Nicolas, de Mey Johan, Vandemeulebroucke Jef, Registration strategies for multi-modal whole-body MRI mosaicing : Registration Strategies for Multi-Modal Whole-Body MRI Mosaicing, 10.1002/mrm.26787
  112. Wang Shijun, Summers Ronald M., Machine learning and radiology, 10.1016/j.media.2012.02.005
  113. Chenevert Thomas L., Galbán Craig J., Ivancevic Marko K., Rohrer Susan E., Londy Frank J., Kwee Thomas C., Meyer Charles R., Johnson Timothy D., Rehemtulla Alnawaz, Ross Brian D., Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies, 10.1002/jmri.22363
  114. Messiou C., Collins D. J., Morgan V. A., deSouza N. M., Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility, 10.1007/s00330-011-2116-4
  115. Weller A., Eur Radiol (2017)
  116. Blackledge M.D., Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease. PLoS One (2016)
  117. Biederer J., Beer M., Hirsch W., Wild J., Fabel M., Puderbach M., Van Beek E. J. R., MRI of the lung (2/3). Why … when … how?, 10.1007/s13244-011-0146-8
  118. Biederer Jürgen, Mirsadraee S., Beer M., Molinari F., Hintze C., Bauman G., Both M., Van Beek E. J. R., Wild J., Puderbach M., MRI of the lung (3/3)—current applications and future perspectives, 10.1007/s13244-011-0142-z
  119. Kumar Shivani, Liney Gary, Rai Robba, Holloway Lois, Moses Daniel, Vinod Shalini K, Magnetic resonance imaging in lung: a review of its potential for radiotherapy, 10.1259/bjr.20150431
  120. Biederer Jürgen, Schoene Arne, Freitag Sandra, Reuter Michael, Heller Martin, Simulated Pulmonary Nodules Implanted in a Dedicated Porcine Chest Phantom: Sensitivity of MR Imaging for Detection, 10.1148/radiol.2272020635
  121. Bergin C J, Pauly J M, Macovski A, Lung parenchyma: projection reconstruction MR imaging., 10.1148/radiology.179.3.2027991
Bibliographic reference Pasoglou, Vasiliki ; Michoux, Nicolas ; Larbi, Ahmed ; Van Nieuwenhove, Sandy ; Lecouvet, Frédéric. Whole Body MRI and oncology: recent major advances. In: British Journal of Radiology, Vol. 91, no. 1090, p. 20170664 (2018)
Permanent URL http://hdl.handle.net/2078.1/194733